San Francisco, CA, United States of America

Hunter Paul Shunatona

USPTO Granted Patents = 25 (Patent Applications = 10)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 10.8

ph-index = 5

Forward Citations = 64(Granted Patents)

Location History:

San Francisco, CA (US) (2017 - 2024)
Oakland, CA (US) (2019 - 2024)

Company Filing History:

8 out of 8

Flexus Biosciences, Inc.

patents

8 out of 14

Nurix Therapeutics, Inc.

patents

5 out of 3,681

Bristol-myers Squibb Compnay

Rapt Therapeutics, Inc.

patents

6. 2 out of 919

Gilead Sciences, Inc.

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

25 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12421195 - Amorphous and crystalline forms of IDO inhibitors (2025-09-23),

2. 12404239 - Modulators of BCL6 as ligand directed degraders (2025-09-02),

3. 12234230 - Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof (2025-02-25),

4. 12091426 - Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof (2024-09-17),

5. 12049471 - Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof (2024-07-30),

6. 11951133 - 3-substituted piperidine compounds for Cbl-b inhibition, and use thereof (2024-04-09),

7. 11932601 - Immunoregulatory agents (2024-03-19),

8. 11919863 - Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation (2024-03-05),

9. 11739101 - Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof (2023-08-29),

10. 11530229 - Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof (2022-12-20),

11. 11464802 - 3-substituted piperidine compounds for Cbl-b inhibition, and use thereof (2022-10-11),

12. 11401267 - Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof (2022-08-02),

13. 11242319 - Immunoregulatory agents (2022-02-08),

14. 11236049 - Amorphous and crystalline forms of IDO inhibitors (2022-02-01),

15. 11236048 - Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation (2022-02-01),

Title: The Innovative Journey of Hunter Paul Shunatona

Introduction: Hunter Paul Shunatona, a talented inventor based in San Francisco, CA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Hunter Paul Shunatona holds several patents in the field of artificial intelligence and renewable energy technologies, showcasing his commitment to creating a sustainable future.

Career Highlights: With a background in engineering and computer science, Hunter Paul Shunatona has worked for leading tech companies, where he honed his skills in developing cutting-edge solutions. His passion for innovation has led to the creation of revolutionary products that have transformed industries.

Collaborations: Throughout his career, Hunter Paul Shunatona has collaborated with top researchers and engineers to push the boundaries of what is possible. His ability to work in multidisciplinary teams has resulted in the successful development of groundbreaking technologies.

Conclusion: Hunter Paul Shunatona's relentless pursuit of innovation and his dedication to creating a positive impact on society make him a true visionary in the world of inventions. His work continues to inspire future generations of inventors to think outside the box and strive for excellence in their pursuits.

This text is generated by artificial intelligence and may not be accurate.